Products

Catalog # Product Namesort icon Size Storage Bio Cat. Status
08-730-100 Adenovirus-2 Infected Cell DNA 100 µL -20˚C
10-266-000 Adenovirus-5 Purified Virus 1 mg -70˚C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
08-947-250 Adenovirus-5 Quantitated Viral DNA 250 µL -20˚C
08-942-250 BKV MM Strain Quantitated Viral DNA 250 µL -20˚C
10-265-000 Chlamydia trachomatis LGV-II 434 Strain Heat-Inactivated Elementary Bodies 1 mL -70˚C
08-931-000 Chlamydia trachomatis LGV-II 434 Strain Quantitated DNA 250 µL -20˚C
08-932-250 Chlamydophila pneumoniae CDC-CWL-011 Strain Quantitated DNA 250 µL -20˚C
10-144-000 CMV AD169 Strain Purified Viral Lysate (1 mg/mL) 1 mg -70˚C
10-144-PNK CMV AD169 Strain Purified Viral Lysate (100 µg/mL) 1 mL -70˚C
10-275-500 CMV AD169 Strain Purified Virus, β-PL Inactivated 0.5 mg -70˚C New ProductNew product
08-925-000 CMV AD169 Strain Quantitated Viral DNA 250 µL -20˚C
03-020-050 Delectinized Interleukin-2 50 mL -70˚C
10-272-000 Dengue-1 Hawaii Strain Purified Viral Lysate 1 mL -70˚C New ProductNew product
13-150-100 EBV anti-(EA-R) protein p17 100 µg -20˚C
10-147-000 EBV B95-8 Strain (Type 1) Purified Viral Lysate 1 mg -70˚C
10-115-000 EBV B95-8 Strain (Type 1) Purified Virus 1 mg -70˚C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
08-926-000 EBV B95-8 Strain (Type 1) Quantitated Viral DNA 250 µL -20˚C
10-523-001 EBV Nuclear Antigen-1 (EBNA-1) Recombinant protein 1 mL -70˚C
10-523-025 EBV Nuclear Antigen-1 (EBNA-1) Recombinant protein 25 mL -70˚C
10-501-001 EBV P3HR1 Strain Inactivated Cell Extract 1 mL -70˚C
10-501-025 EBV P3HR1 Strain Inactivated Cell Extract 25 mL -70˚C
10-502-001 EBV P3HR1 Strain Viral Capsid Antigen, Immunoaffinity Purified 1 mL -70˚C
10-502-025 EBV P3HR1 Strain Viral Capsid Antigen, Immunoaffinity Purified 25 mL -70˚C
07-211-001 Elutriated Human Adult Monocytes (Multiple Donors) 1.0 mL -110˚C New ProductNew product
07-210-001 Elutriated Human Adult Monocytes - Frozen 1 mL -70˚C
10-250-000 FeLV Thielen Strain Purified Virus 1 mg -70˚C
10-531-001 H9 Uninfected Cell Extract 1.0 mL -70˚C
10-505-001 HFS Uninfected Cell Extract 1 mL -70˚C
15-401-000 HHV-6 IgG Antibody ELISA Kit Kit 2 to 8˚C
15-301-000 HHV-6 IgG Antibody IFA Kit Kit 2 to 8˚C
13-138-100 HHV-6A Early Protein p41/38 100 µg -20˚C
13-139-001 HHV-6A Early Protein p41/38 (cell culture supernatant) 1 mL -20˚C
10-241-500 HHV-6A GS Strain Purified Viral Lysate 0.5 mg -70˚C
08-945-250 HHV-6A GS Strain Quantitated Viral DNA 250 µL -20˚C
13-217-001 HHV-6A MAb to gp82/105 (cell culture supernatant) 1 mL -20˚C
13-216-100 HHV-6A/B MAb to early Phosphoprotein p41 100 µg -20˚C
13-218-100 HHV-6A/B MAb to gp116/64/54 100 µg -20˚C
13-219-001 HHV-6A/B MAb to gp116/64/54 (cell culture supernatant) 1 mL -20˚C
08-923-000 HHV-6B Z-29 Strain Quantitated Viral DNA 250 µL -20˚C
08-950-250 HHV-7 H7-4 Strain Quantitated DNA Control 250 µL -20˚C New ProductNew product
15-321-000 HHV-7 IgG Antibody IFA Kit Kit 2 to 8˚C
13-108-100 HIV-1 anti-gp120 env 100 µg -20˚C
13-105-100 HIV-1 anti-gp120 env (aa 307-320) 100 µg -20˚C
13-104-100 HIV-1 anti-gp41 env 100 µg -20˚C
13-103-100 HIV-1 anti-p17 gag 100 µg -20˚C
13-102-100 HIV-1 anti-p24 gag 100 µg -20˚C
13-137-100 HIV-1 anti-p66/51 pol 100 µg -20˚C
10-177-000 HIV-1 Ba-L Strain Direct Pelleted Virus (500X) 1.0 mL -70˚C ABiological Substance, Category A
UN 2814
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-124-000 HIV-1 IIIB Strain Direct Pelleted Virus (1000X) 1 mL -70˚C ABiological Substance, Category A
UN 2814
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-124-PNK HIV-1 IIIB Strain Direct Pelleted Virus (100X) 1 mL -70˚C ABiological Substance, Category A
UN 2814
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
14-102-050 HIV-1 IIIB Strain gp120 Purified Native Glycoprotein 50 µg -70˚C
14-103-050 HIV-1 IIIB Strain gp160 env Purified Native Glycoprotein 50 µg -70˚C
14-127-050 HIV-1 IIIB Strain gp160 Recombinant Viral Protein 50 µg -70˚C
10-530-001 HIV-1 IIIB Strain Inactivated Cell Extract 1.0 mL -70˚C
10-530-025 HIV-1 IIIB Strain Inactivated Cell Extract 25 mL -70˚C
08-707-000 HIV-1 IIIB Strain Infected Cell DNA 100 µL -20˚C
14-108-050 HIV-1 IIIB Strain nef Recombinant Viral Protein 50 µg -70˚C
14-101-050 HIV-1 IIIB Strain p24 gag Purified Native Protein 50 µg -70˚C
14-126-050 HIV-1 IIIB Strain p24 Recombinant Viral Protein 50 µg -70˚C
14-128-050 HIV-1 IIIB Strain p66 (Reverse Transcriptase) Recombinant Viral Protein 50 µg -70˚C
10-119-000 HIV-1 IIIB Strain Purified Viral Lysate 1 mg -70˚C
10-118-000 HIV-1 IIIB Strain Purified Virus 1 mg -70˚C ABiological Substance, Category A
UN 2814
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
13-204-000 HIV-1 IIIB Strain Rabbit anti-gp120 Polyclonal 0.5 mL -20˚C
13-203-000 HIV-1 IIIB Strain Rabbit anti-p24 Polyclonal 0.5 mL -20˚C
14-129-050 HIV-1 MN Strain gp120 Recombinant Viral Protein 50 µg -70˚C
14-109-050 HIV-1 pHXB2 Strain gp41 Recombinant Viral Protein 50 µg -70˚C Call for availabilityCall for availability
10-228-000 HIV-1 pHXB2D Strain Direct Pelleted Virus (1000X) 1 mL -70˚C ABiological Substance, Category A
UN 2814
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-226-000 HIV-1 pHXB2D Strain Direct Pelleted Virus (500X) 1 mL -70˚C ABiological Substance, Category A
UN 2814
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
08-708-000 HIV-2 NIH-Z Strain Infected Cell DNA 100 µL -20˚C
10-128-000 HIV-2 NIH-Z Strain Purified Viral Lysate 1 mg -70˚C
10-127-000 HIV-2 NIH-Z Strain Purified Virus 1 mg -70˚C ABiological Substance, Category A
UN 2814
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. 		Discontinued - some remainingDiscontinued - some remaining
14-110-050 HIV-2 ST Strain gp36 Recombinant Viral Protein 50 µg -70˚C
08-754-100 HPV-16 Transformed Cell DNA 100 µL -20˚C
08-755-100 HPV-18 Transformed Cell DNA 100 µL -20˚C Call for availabilityCall for availability
10-529-001 HSB-2 Uninfected Cell Extract 1.0 mg -70˚C
10-515-001 HSV-1 MacIntyre Strain Inactivated Cell Extract 1 mL -70˚C
10-515-025 HSV-1 MacIntyre Strain Inactivated Cell Extract 25 mL -70˚C
10-145-000 HSV-1 MacIntyre Strain Purified Viral Lysate 1 mg -70˚C
10-110-000 HSV-1 MacIntyre Strain Purified Virus 1 mg -70˚C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
08-921-000 HSV-1 MacIntyre Strain Quantitated Viral DNA 250 µL -20˚C
10-516-001 HSV-2 G Strain Inactivated Cell Extract 1 mL -70˚C
10-516-025 HSV-2 G Strain Inactivated Cell Extract 25 mL -70˚C
10-146-000 HSV-2 G Strain Purified Viral Lysate 1 mg -70˚C
10-111-000 HSV-2 G Strain Purified Virus 1 mg -70˚C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
08-922-000 HSV-2 G Strain Quantitated Viral DNA 250 µL -20˚C
08-711-000 HTLV-I MT-2 Strain Infected Cell DNA 100 µL -20˚C
10-113-000 HTLV-I MT-2 Strain Purified Viral Lysate 1 mg -70˚C
10-112-000 HTLV-I MT-2 Strain Purified Virus 1 mg -70˚C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
08-710-000 HTLV-II C3-44/Mo Strain Infected Cell DNA 100 µL -20˚C
10-276-000 Human Influenza A/2/Japan/305/57 (H2N2) Purified Virus, UV-Inactivated 1.0 mg -70˚C New ProductNew product
10-259-000 Human Influenza A/2/Japan/305/57 Purified Virus (H2N2) 1 mg -70˚C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-201-500 Human Influenza A/Hong Kong/8/68 Purified Virus (H3N2) 0.5 mg -70˚C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-268-500 Human Influenza A/New Caledonia/20/99 Purified Virus (H1N1) 0.5 mg -70˚C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-210-500 Human Influenza A/PR/8/34 Purified Virus (H1N1) 0.5 mg -70˚C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-273-500 Human Influenza A/PR/8/34 Purified Virus (H1N1), UV-Inactivated 0.5 mg -70˚C
10-267-500 Human Influenza A/PR/8/34 Purified Virus (H1N1), β-PL Inactivated 0.5 mg -70˚C
10-220-500 Human Influenza B/Lee/40 Purified Virus 0.5 mg -70˚C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
P2-203-050 Human Serum AB, Sterile, Growth Performance Tested 50 mL -20˚C New ProductNew product
10-601-001 Immunoassay Stabilizer 1 L 2 to 8˚C
10-280-500 Influenza A/California/4/2009 (H1N1) Purified Virus 0.5 mg -70˚C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. 		New ProductNew product
10-281-500 Influenza A/Mexico/4108/2009 (H1N1) Purified Virus 0.5 mg -70˚C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. 		New ProductNew product
08-943-250 JCV MAD1 Strain Quantitated Viral DNA 250 µL -20˚C
15-501-000 KSHV/HHV-8 IgG Antibody ELISA Kit Kit 2 to 8˚C
15-330-000 KSHV/HHV-8 IgG Antibody IFA Kit Kit 2 to 8˚C
08-938-250 KSHV/HHV-8 KS-1 Strain Quantitated Viral DNA 250 µL -20˚C
13-213-100 KSHV/HHV-8 MAb to ORF K8.1 A 100 µg -20˚C
13-212-100 KSHV/HHV-8 MAb to ORF K8.1 A/B 100 µg -20˚C
13-211-100 KSHV/HHV-8 MAb to ORF59 100 µg -20˚C
13-210-100 KSHV/HHV-8 MAb to ORF73 (anti-LNA-1) 100 µg -20˚C
13-214-050 KSHV/HHV-8 Rabbit antibody vIL-6 Polyclonal 50 µg -20˚C
10-528-001 MOLT-3 Uninfected Cell Extract 1.0 mg -70˚C
08-949-250 Mycobacterium tuberculosis Quantitated Bacterial DNA 250 µL -20˚C New ProductNew product
08-946-250 Mycoplasma pneumoniae Quantitated DNA 250 µL -20˚C
10-263-000 Neisseria gonorrhoeae Heat-Inactivated Cells 1 mL -70˚C
10-262-000 Neisseria gonorrhoeae Viable Cells 1 mL -70˚C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
08-924-000 Neisseria gonorrhoeae Quantitated Bacterial DNA 250 µL -20˚C
03-001-050 Purified Interleukin-2 50 mL -110˚C
13-222-100 Rabbit anti-Vaccinia Polyclonal 100 µg -20˚C
10-249-000 RSV A-2 Strain Direct Pelleted Virus (1000X) 1 mL -70˚C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-248-000 RSV A-2 Strain Purified Viral Lysate (1 mg/mL) 1 mg -70˚C
10-248-PNK RSV A-2 Strain Purified Viral Lysate (100 µg/mL) 1 mL -70˚C
10-247-000 RSV A-2 Strain Purified Virus (1 mg/mL) 1 mg -70˚C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-247-PNK RSV A-2 Strain Purified Virus (100 µg/mL) 1 mL -70˚C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-270-000 Rubella HPV77 Strain Purified Virus, UV-Inactivated 1 mg -70˚C
10-518-001 Rubeola/Measles Edmonston Strain Inactivated Cell Extract 1 mL -70˚C
10-518-025 Rubeola/Measles Edmonston Strain Inactivated Cell Extract 25 mL -70˚C
13-113-100 SIV mac251 Strain anti-p27 gag (cross reacts w/HIV-1 and -2 proteins) 100 µg -20˚C
13-112-100 SIV mac251 Strain anti-p27 gag (does not react w/HIV-1 or -2 proteins) 100 µg -20˚C
10-150-000 SIV mac251 Strain Purified Viral Lysate 1 mg -70˚C
10-149-000 SIV mac251 Strain Purified Virus 1 mg -70˚C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-153-000 SRV-1 Macaque Strain Purified Viral Lysate 1 mg -70˚C
10-152-000 SRV-1 Macaque Strain Purified Virus 1 mg -70˚C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-218-000 SRV-2 Purified Virus 1 mg -70˚C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-223-000 SRV-5 Purified Virus 1 mg -70˚C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-279-001 Toxoplasma gondii RH strain Purified Tachyzoites Lysate 1.0 mL -70˚C New ProductNew product
10-279-025 Toxoplasma gondii RH strain Purified Tachyzoites Lysate 25 mL -70˚C New ProductNew product
08-948-250 Toxoplasma gondii RH Strain Quantitated DNA 250 µL -20˚C
08-940-250 Vaccinia Lister Quantitated Viral DNA 250 µL -20˚C
10-252-000 Vaccinia Lister Strain Purified Virus 1 mg -70˚C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-253-000 Vaccinia Lister Strain Purified Virus, UV-Inactivated 1 mg -70˚C
10-254-000 Vaccinia WR Strain Purified Virus 1 mg -70˚C BBiological Substance, Category B
UN 3373
Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form.

Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package.
10-255-000 Vaccinia WR Strain Purified Virus, UV-Inactivated 1 mg -70˚C
10-508-001 Vero Uninfected Cell Extract 1 mL -70˚C
10-514-001 VZV Rod Strain Inactivated Cell Extract 1 mL -70˚C
10-514-025 VZV Rod Strain Inactivated Cell Extract 25 mL -70˚C
08-927-000 VZV Rod Strain Quantitated Viral DNA 250 µL -20˚C
CSVXLS